December 19, 2014
VIA EMAIL
Jeffrey P. Riedler
Assistant Director
United States Securities and Exchange Commission
Washington, D.C. 20549
Re: | Nascent Biotech Inc. Registration Statement on Form 10-12(g) File No. 000-55299 |
Dear Mr. Riedler:
In response to your letter of November 24, 2014 regarding the above-referenced issuer, Nascent Biotech, Inc. (the "Company"), please be advised that the Company is in the process of responding to the Staff’s comments in that letter. As a follow-up to our conversation yesterday afternoon, please be advised that the Company anticipates filing its response to the comment letter and its amended Form 10 after the first of the year, due to the upcoming holidays.
Please contact me with any questions.
Sincerely,
MCDOWELL ODOM LLP | ||
| /s/ Claudia McDowell | ||
| Claudia J. McDowell |
/CJM
Page 1
28494 Westinghouse Place, Suite 305| Valencia, California 91355
661.449.9630 Business | 818.475.1819 Facsimile |claudia@mcdowellodom.com
www.mcdowellodom.com